My Diabetes Care (MDC) Mobile for Diabetes Mellitus, Type 2

Phase-Based Progress Estimates
Vanderbilt University Medical Center, Nashville, TN
Diabetes Mellitus, Type 2+1 More
My Diabetes Care (MDC) Mobile - Other
All Sexes
What conditions do you have?

Study Summary

The purpose of this study is to conduct a prospective, longitudinal study on the My Diabetes Care (MDC) mobile intervention to assess usage patterns, user experience, and to uncover errors in functionality prior to a larger interventional trial.

Eligible Conditions

  • Diabetes Mellitus, Type 2

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Diabetes Mellitus, Type 2

Study Objectives

3 Primary · 7 Secondary · Reporting Duration: One month follow-up (t1)

Baseline (t0) to one month follow-up (t1)
Change in Diabetes Distress
Change in Diabetes Knowledge
Change in Diabetes Readiness for Change
Change in Diabetes Self-Care
Change in Diabetes Self-Efficacy
Change in Knowledge of Diabetes Measures
Change in Medication Adherence
One month follow-up (t1)
System Usage
User Experience - Acceptance

Trial Safety

Safety Progress

1 of 3

Other trials for Diabetes Mellitus, Type 2

Trial Design

1 Treatment Group

My Diabetes Care (MDC) Mobile
1 of 1
Experimental Treatment

90 Total Participants · 1 Treatment Group

Primary Treatment: My Diabetes Care (MDC) Mobile · No Placebo Group · N/A

My Diabetes Care (MDC) Mobile
Experimental Group · 1 Intervention: My Diabetes Care (MDC) Mobile · Intervention Types: Other

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: one month follow-up (t1)

Trial Background

Prof. William Martinez,, MD
Principal Investigator
Vanderbilt University Medical Center
Closest Location: Vanderbilt University Medical Center · Nashville, TN
Photo of vanderbilt university medical center  1Photo of vanderbilt university medical center  2Photo of vanderbilt university medical center  3
2006First Recorded Clinical Trial
20 TrialsResearching Diabetes Mellitus, Type 2
1019 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 7 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have type 2 diabetes.\n

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.